A randomized, open ‐label, multicentre, parallel‐controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: the Merit study

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - July 2, 2018 Category: Endocrinology Authors: Lixin Guo MD , Li Chen MD , Baocheng Chang MD, PhD , Liyong Yang MD , Yu Liu MD , Bo Feng MD Source Type: research